# Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus

> **NCT04216303** · — · WITHDRAWN · sponsor: **Methodist Health System**

## Conditions studied

- Diabetes
- Liver Transplant; Complications
- Kidney Transplant Failure

## Interventions

- **DIAGNOSTIC_TEST:** hemoglobin A1c

## Key facts

- **NCT ID:** NCT04216303
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-09-12
- **Primary completion:** 2021-08-19
- **Final completion:** 2021-08-19
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI decided to stop the study
- **Last updated:** 2021-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04216303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04216303, "Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04216303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*